Shares of Medical Properties Trust (MPW) soared over 5% in pre-market trading on Friday, following actions from analysts covering the healthcare real estate investment trust (REIT).
BofA analyst Joshua Dennerlein lowered the firm's price target on MPW to $3 from $3.50, but maintained an Underperform rating on the stock. While a price target cut typically weighs on a stock, the relatively modest reduction may not have had a significant impact in this case.
Meanwhile, a separate analysis from Zacks Investment Research highlighted some key factors that could be driving investor interest in MPW. The report noted MPW's attractive valuation compared to peers, as reflected in its Value Style Score of C, indicating the stock is trading roughly in line with the industry average.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。